✦ LIBER ✦

Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia

✍ Scribed by Gloria N. Mattiuzzi; Jorge E. Cortes; Deborah A. Blamble; B. Nebiyou Bekele; Lianchun Xiao; Maria Cabanillas; Gautam Borthakur; Susan O'Brien; Hagop Kantarjian

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 314 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25365

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 trial results with the novel neu

Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy

✍ Wichit Arpornwirat; Istvan Albert; Vincent L. Hansen; Jeremey Levin; Rajesh R. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB